CGM 2025

Exosens combined general meeting of 23 may 2025

PRESS RELEASE
MÉRIGNAC, FRANCE – 26 MAY 2025

The Combined General Meeting (ordinary and extraordinary) of Exosens shareholders (the ‘Company’) was held on Friday 23 May 2025, chaired by Mr Jean-Hubert Vial, Chairman of the Board of Directors.

The meeting was attended by Mr Jérôme Cerisier, Chief Executive Officer, Ms Quynh-Boï Demey, Chief Financial Officer, Ms Bella Zisère, Human Resources Director, and the Company's Statutory Auditors.

HLD Europe and Bpifrance Participations, designated as the shareholders with the largest number of voting rights, acted as scrutineers.
The General Meeting, convened with a quorum representing 77.83% of the Company’s share capital in respect of ordinary resolutions and 77.53% in respect of extraordinary resolutions, approved all resolutions submitted for its consideration.

Approval of the 2024 financial statements

The shareholders approved the parent company and consolidated financial statements for the financial year ended 31 December 2024.

Dividends

The General Meeting approved the payment of a cash dividend of €0.10 per share, with payment commencing on 30 May 2025.

Governance

The General Meeting also approved the appointment of Bpifrance Investissement as a director, represented by Ms Dorianne Bonfils.

The presentation, audiovisual replay of the General Meeting and detailed voting results are available here:

Download the full press release - EN

Investor Relations

Laurent Sfaxi, l.sfaxi@exosens.com

CGM 2025

Exosens combined general meeting of 23 may 2025

Related content